Adapting to Progress: Vorolanib Intravitreal Implant

from Let’s Talk Ophthalmology: an Evolve Medical Education Podcast · host Evolve Medical Education, LLC

The pipeline for the treatment of wet age-related macular degeneration includes therapies that focus on new molecular targets. Carl J. Danzig, MD, FASRS, discusses a tyrosine kinase inhibitor. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to view more education? Click here.

Episode metadata supplied by the publisher feed · Published Jan 16, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Adapting to Progress: Vorolanib Intravitreal Implant

0:00 12:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Let’s Talk Ophthalmology: an Evolve Medical Education Podcast?

This episode is 12 minutes long.

When was this Let’s Talk Ophthalmology: an Evolve Medical Education Podcast episode published?

This episode was published on January 16, 2025.

Can I download this Let’s Talk Ophthalmology: an Evolve Medical Education Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!